NLRP3 and atrial fibrillation: Their findings showed that glibenclamide treatment attenuated atrial fibrosis, restored epicardial conduction and conduction homogeneity, and decreased the inducibility of AF, all linked to the inhibition of the NLRP3 inflammasome [120].